Developing treatments for ultra-rare diseases presents fundamental challenges for traditional evidence generation, necessitating a paradigm shift in how scientific rigor…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
Los Angeles, CA – A novel drug candidate for glioblastoma, KTM-101, developed by researchers at the University of California, Los…
Read More
A decade in the making: How functional NAMs are redefining cardiac safety assessment
The rapid acceleration in the adoption of New Approach Methodologies (NAMs) for drug safety testing, often perceived as a sudden…
Read More
EClinical Solutions Study Models 241% ROI from AI-Powered Clinical Trial Data Platform
A groundbreaking study, commissioned by eClinical Solutions and modeled by Hobson & Company, has unveiled compelling evidence of the transformative…
Read More
Protecting Innovation in a Borderless Pharma Economy: The Reality of Globalized Pharma Innovation
The pharmaceutical industry, a bedrock of global health and economic advancement, is increasingly defined by its borderless nature. Today’s drug…
Read More
Top Pharma Companies Set Sustainability Goals, But Emissions Are Still Increasing
The healthcare industry, a cornerstone of global well-being, paradoxically contributes an estimated 4.4% of total global emissions annually, placing it…
Read More
Traumatic brain injury and Alzheimer’s disease, common neuroinflammatory pathologies and therapeutic potential
Traumatic brain injury (TBI) stands as a profound and pervasive global health crisis, impacting an estimated 69 million individuals each…
Read More
Immunai’s Digital "Plumbing" Secures Third Expansion with AstraZeneca, Deepening AI Integration Across Clinical Pipeline
Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has announced its third significant…
Read More
Eli Lilly’s Retatrutide Demonstrates Unprecedented Weight Loss with Notable Side Effect Profile in Phase 3 Trials
Eli Lilly and Company’s investigational drug, retatrutide, a groundbreaking triple hormone receptor agonist, has delivered an average weight loss of…
Read More
BioNTech’s Post-Pandemic Pivot: From €19 Billion Vaccine Bonanza to Oncology’s €16.8 Billion Bet Amidst Job Cuts and Shifting mRNA Landscape
The German biotechnology firm BioNTech, a name synonymous with the rapid development of the world’s first widely authorized mRNA COVID-19…
Read More
